european network for infectious diseases - eunid.eu workshop 22-23 may... · the diseases/pa...

1

EU contract No:2003207

European Network for Infectious Diseases

Aims

• enhance co-operation and exchange of

information on highly infectious diseases (HIDs)

among ID clinicians, epidemiologists and public

health experts;

• to enhance preparedness and response within

Europe to health threats from HIDs.


2

• 16 Participating

countries:

Austria, Belgium,

Denmark, Estonia,

Finland, France,

Germany, Greece,

Ireland, Italy,

Luxembourg, The

Netherlands, Portugal,

Spain, Sweden and UK


The EUNID projectEU contract No:2003207

EUNID consortium

Coordination Team

Co-opted expertsNational representatives

(partners)

3

Coordination Team and Co-opted experts

The Coordination Team is based in Rome, Italy, at the National Institute for Infectious

Diseases “Lazzaro Spallanzani”.

Project Leader Dr. Giuseppe Ippolito

Scientific Coordinator Dr. Vincenzo Puro

Project Coordinator Dr. Francesco Maria Fusco

Collaborators: Dr. De Carli Gabriella

Dr.Fabio Soldani

Dr. Carla Nisii

Dr. Simone Lanini

Project Secretary Ms. Ramona Iacovino

Experts Dr. Julia Heptonstall (Scarborough and North East Yorkshire

NHS Trust, Scarborough, United Kingdom)

Dr. Agoritza Baka (Hellenic Center for Infectious Disease

Control, Athens, Greece)

Dr. Philippe Brouquì (BSL3 Unit : Service des Maladies

Austria Dr. N. Vetter – Otto-Wagner-Spital , Wien

Belgium Dr. R. Peleman - University Hospital, Gent

Denmark Dr. P. Skinhoj – Rigshospitalet, Copenaghen

Estonia Dr. K. Ott - West Tallinn Central Hospital, Tallinn

Finland Dr. H. Siikamaki - Helsinki University Central Hospital , Helsinki

France Dr. C. Perronne – Hopital Raymond Poincare, Paris

Germany Dr. H.R. Brodt - Klinikum der J. W. Goethe Universitaet, Frank Frankfurt

Greece Dr. M. Lazanos - Hellenic Center for Infectious Disease Control, Athens

Ireland Dr. G. Sheehan – Univer. College of Dublin Mater Misericordiae Hospital

Luxembourg Dr. R. Hemmer - Centre Hospitalier, Luxembourg

The Netherlands Dr. A.I.M. Hoepelman - University Medical Center, Utrecht

Portugal Dr. K. Mansinho - Hospital de Egas Moniz, Lisbona

Spain Dr. A. Trilla - Universitat Autonoma de Barcelona, Barcelona

Sweden Dr. P. Follin - Swedish Institute for Infectious Disease Control, Stockholm

United Kingdom Dr. Barbara Bannister - Royal Free Hospital, London

EUNID partners

4

Council Directive 89/391/EEC of 12 June 1989 on the Council Directive 89/391/EEC of 12 June 1989 on the

introduction of measures to encourage improvements in introduction of measures to encourage improvements in

the safety and health of workers at workthe safety and health of workers at work

Directive 2000/54/EC of the European Parliament on the Directive 2000/54/EC of the European Parliament on the

protection of workers from risks related to exposure to protection of workers from risks related to exposure to

biological agents at work biological agents at work -- 18 September 200018 September 2000

Legislative framework

Legislative framework

-- the the risk of exposurerisk of exposure must be must be reduced to as low a level as necessaryreduced to as low a level as necessary

-- design of work processes and engineering control measuresdesign of work processes and engineering control measures so as to so as to

avoid or minimize the release of biological agents into the placavoid or minimize the release of biological agents into the place of work;e of work;

-- collective protection measurescollective protection measures and/or, and/or, where exposure cannot be where exposure cannot be

avoided by other meansavoided by other means, , individualindividual protection measures;protection measures;

-- adapting to technical progressadapting to technical progress; ;

5

Methods and management of the

project

• Literature review

• International and national documents

• Structured questionnaires

• Exchange of data and procedures and sharing of draft documents, through:– E-mail and phone contacts

– Project web-site

• Consensus reached during meetings.

6

Exchange of data

• During the meetings, each country representative

presented a short presentation about their isolation

facilities, and about the policies for isolation in their own

country

EUNID meetings

Rome, May 27-28, 2005

London, April 7-8, 2005

And the 3° and final meeting, tomorrow!

7

Deliverables


Definition and identification of HID

Archive of National guidelines and protocols

Inventory of HIU and national referral centres

Definition of minimal requirements for High Isolation Units

Consensus on PPE use

Core curriculum and training course proposal

Definition of HIDs

According to EUNID consortium, a highly

infectious disease is:

• transmissible from person-to-person;

• causes life-threatening illness;

• presents a serious hazard in health care settings

and in the community, requiring specific control

measures.

8

Definition HIDs

According to EUNID consortium, the agents that satisfy the definition are:

• Human-to-human transmissible Viral haemorrhagic fevers (VHF)

viruses;

• SARS Co-V;

• Multi- and Extensively- Drug Resistant M tuberculosis;

• Emerging highly pathogenic strains of influenza virus;

• Smallpox and other orthopox infections (eg monkeypox, camel pox,

but excluding vaccinia virus)

• Other emerging highly pathogenic agents, including agents of

deliberate release (eg pneumonic plague)

What has already been done:

Archive

• Archive of national guidelines on isolation and management of patients with HIDs from all the participating countries;

• archive of relevant

international guidelines on

the same issue

(available on

www.eunid.com ).


9

Inventory of Isolation Facilities in Europe

Questionnaire collected data on:

• Number of hospitals and hospital beds provided

with negative pressure and anteroom;

• Technical features of these beds (number of air

changes per hour, direct connection with lab,

way of air exhausting);

• Logistic features of these units;

• Number of beds provided with IC capabilities.

What has already been done

10

HIU ICHIU

< 6cph

HIU

> 6cph

HIU+ BSL3/4

< 6cph

HIU+ BSL3/4

> 6cph

32312 (1- IC)3 (2-IC)29Sweden

2913174911114151Total

3504212UK

NANANA33Portugal

4 (PD)41Netherlands

7151Luxembourg

245 (PD)2432 (10)2Italy

6710Ireland

NA6725Greece

10464105Germany

67 rooms provided with negative pressure 17France

196610Finland

151Estonia

385Denmark

Austria

N° of hospital bedsN° of

hospital

Country

For each PPE a proposal was shown for discussion with a rating strength of recommendation:

R “recommended”

Ch “to be Considered” but conferring “Higher protection”

Cl “to be Considered” but conferring “Lower protection”

D “discouraged”

Both for standard condition and high risk procedures

EUNID Agreement on PPE in HIUs

11

Viral Haemorrhagic fevers

ClChRRClClRClstandard

DChRRDDRDhigh risk

hair

covering

surgical

boots

shoe

covering

Full body

tyvek suit

plastic

apron

Imperm

. gown

double

gloves

single

gloves

Body

protection

Ch

Ch

Hood with

face shield

DDClRStandard

DDDRHigh risk

Safety

glasses

eyeglasses

with lateral

shield

Goggles

Full face

shield/m

ask

Face

protection

ChRClDStandard

RClDDHigh risk

Mask/PAPR with

HEPA filterFFP3FFP2

Surgical

mask

Respiratory

protection

• PPE must be worn before entering the patient room;

• a pre-defined sequence to remove PPE after their use has to be known

by HCWs, who should be trained in removing PPE;

• the sequence depends on the PPE chosen;

• the HCW should be extremely careful in removing protection from the

mucous membranes of the face with decontaminated hands, in order to

prevent self-contamination with contaminated PPE or hands

• PPE should be removed in the anteroom, if present. If not, remove

ensuring that neither persons or the environment get contaminated

Donning and Doffing PPE

12


• Definition of a core-curriculum for the infectious

disease clinicians involved in the management of

patients with HIDs.



• Development of training modules.


13

Definition of minimal requirements for High Isolation Units (HIUs):

• Role of HIUs;

• Logistic characteristics;

• Technical issues;

• Facilities and furniture.


Dissemination of results

• Web site

• Posters and

communications at

international meetings

• Articles on peer-reviewed

journals and

epidemiological bulletins

High Isolation Hospital Beds for Patients

with Highly Infectious Diseases: an

Inventory of Resources in Europe

IMED – Vienna 2007

High Isolation Hospital Beds for Patients with Highly Infectious Diseases: an Inventory of

Resources in Europe

Isolatio n Hospi tal Be ds in EUNID countr ies. De taile d data for eac h country

317 (c on firmed

only )491 (c on firmed only )1114Hospital beds

291 (247 with portabl e

devices)

887556Curre nt

hospitalsTotal (Franc e not

include d)

0Abou t 5042Hospital beds

3

01022Curre nt

hospitals

UK

2312 (1 if IC)3 (2 if IC)0Hospital beds

3

28110Curre nt

hospitalsSweden

No HIRsSpain (Catal onia

only )

0400Hospital beds

4 (port able devices)

0100Curre nt

hospitals

Nether la nds

Data Not AvailableData Not Available00Hospital beds

Data Not Available

333300Curre nt

hospitalsPortugal

01500Hospital beds

7

0100Curre nt

hospitals

Luxem burg

024302Hospital beds

245 (po rtable devices)

0201Curre nt

hospitalsItaly

06700Hospital beds

0

01000Curre nt

hospitalsIreland

67000Hospital beds

Data Not Available

25000Curre nt

hospitalsGreece

46410Hospital beds

10

1223Curre nt

hospitalsGermany

67 negative p ressur e roo ms in 17 hospitals. Furt her dat a not available.France

06600Hospital beds

19

01000Curre nt

hospitals

Finla nd

15000Hospital beds

0

1000Curre nt

hospitalsEston ia

03800Hospital beds

0

0500Curre nt

hospitals

Denmark

No HIRs in the count ryAustr ia

Hospi tal beds in HIR

with I C capa bili tiesHIR wit h < 6 acphHIR wit h ≥ 6 ac ph

HIR wit h < 6 acph + direct

connec tion with a BSL 3- 4 lab

HIR wit h ≥ 6 ac ph + direct

connec tion wi th a BSL 3- 4 labCoun tr ies

National Ins titute of Infectio us Dis eases

IRCCS Laz zaro Spallanzani

Via Portuense, 292 – 00149 Rome – Italy

F.M. Fusco, V. Puro, P. Skinhoj, K. Ott, H. Siikamaki, H. R. Brodt, G. Sheehan, R. He mmer, K. Man sinho, A.I.M. H oepel man, P. Follin, M. Ca mpins Ma rti, P. Brouqui, B.

Bannister, G. Ippolito

National Institute fo r Infectio us Diseases L. Spallanzani, Ro me, Italy, Rigshospitalet, Copenaghen, D enma rk, West Tallin n Centr al Hospital , Tallinn, Estonia, Centra l Hospital

Helsinki Unive rsity , Helsin ki, Finland, Klinikum der Joh ann Wolfgang Goethe Unive rsitaet , F rankfu rt, Germany, Univer sity College of Dublin Mater Mise rico rdiae Hospita l,

Dublin, Irelan d, Cent re Hospitalie r de Luxe mbou rg, Luxe mbou rg, Luxe mbou rg, Hospit al de Egas Mo niz, SA, Lisbona, Portugal, U niversi ty Medical Cente r, Ut recht, Nethe rlands,

Swedish Institutefor Infectious Disease Cont rol, Stockhol m, Sweden, Unive rsitat Autono ma de Barc elona, Barcelo na, Spain, Fac ulte de Medecine, Un iversite de la Mediter ranee,

Marse ille, F rance, R oyal F ree Hospital, London, United Kingdo m

Background: In or der to prevent the s preadi ng of Highl y

Infecti ous Di seas es (HID) in the hospital s etti ng, is ol ati on

meas ures are ess enti al.

Accordi ng to the Eur opean Legisl ati on, coll ecti ve

meas ures , i.e. str uctural and

engi neeri ng characteristics,

shoul d have the priority over indi vidual pr otecti ve meas ures. In particular, the avail ability of

hospital rooms eq uipped with negati ve press ure and anteroom

is recommended.

EUNID project

The Eur opean Networ k for Infecti ous Dis ease (EUNID) is

an EC-funded network (EU

contract N° 2003207) of European experts in the management of pati ents with

HID. With the ai m of moni tori ng

the current availability of hospital r ooms appropriate for

the is ol ati on of pati ents with

HID, EUNID performed an inventor y of hos pitals provi ded

with High Isolati on Hospi tal

Rooms i n partici pati ng countri es, their placement and some tec hnic al features.

Definition of HID according to

EUNID A HID is trans missible fro m pe rson to pe rson, causes life -

threatening illness, and pr esents a se rious ha zard in health ca re

setting and in the co m munity, requi ring specific c ontrol measures:

• Viral haemor rhagic fevers ( marbu rg, ebola, Cri mean Congo, and

Lassa), and South American hae mor rhagic feve r, (Junin, Mac hupo ,

Sabia, and Guanarito );

• SARS Co-V;

• Emerging hig hly pathogenic strains of influenza vi rus (figu re 4);

• Smallpox and othe r o rthopox infecti ons (eg monk eypox, camel pox ,

but excluding vaccini a virus )

• Other e merg ing highly p athogenic agents, including agent s of

deliberate release (eg pneu monic p lague)

Methods: A questi onnair e was

drafted by the coordi nati on team, revi ewed and edited by the experts, and s ent to all

national offici als . Ans wers were

discuss ed and revi ewed duri ng

the meeti ngs of EUNID project. We defi ne as High Is ol ati on

Room (HIR) a si ngle or double

room provided with at least negati ve press ure and

anteroom.

Discussion: overall, the number of hospital beds i n HIR i n the EU NID European countries appear adequate to manag e the sporadic i ntroduc tion of HID c ases and s mall outbreaks.

However, differenc es exist among countries, thus, to manag e HID emergencies a trans-

national coll abor ation is req uired. Larger outbr eaks or epidemics coul d be diffi cult to handl e wi th c urrent HIR capacity, and should req uire the us e of healthc are facili ties other than H IR, preferabl y airborne is ol ation rooms without anteroom. T he defici enc y of IC in the

HIRs present in the countr y s houl d repres ent an i nadequac y: cr eati ng and maintai ning

Countries particip ating to

EUNID project

Location of HIR referring to other

hospital fac ilities

2

3

3

4

1

Sep ara te bu ild in g in th e

same ca mpus

Sep ara te ward in the same

building

Not separ ate war d ( mainly

in Infectio us Diseases

Wa rd)

Diff eren t locatio n insidethe co untr y, including

separ ate building

Diff eren t locatio n insidethe co untr y, including

separ ate war d

HIRs in separate building under constru ction in Rome,

Italy

Web s ite:

www.euni d.c om

Contacts: euni d.s ecretar y@i

nmi.it;

fusc o@i nmi.it

Data about sealing a re avail able in 8 count ries: HI Rs are sealed in all c ountries but one

Way of air-exhausting fr om HIRs

6

3

4D irec tly to out side wit h

H EPA filt ra tion

D irec tly to out side

w ithout HEPA filtrat ion

N o dat a

Isolati n g and moni tor ing Avian Flu

A Core Curriculum for Health Care Workers on Training in Management of Highly Infectious

DiseasesNational Ins titute of I nfectio us Dis eas es

IRCCS Laz z ar o Spallanz ani

Via Portuens e, 292 – 00149 Rome – Italy

A. Baka, F.M. Fusco, V . Puro, N. Vette r, P. Skinhoj, K . Ott, H. S iikamaki, H.R. Brodt, P . Follin, B . Bannister , G. De Carli, C. Nisii , J. Heptonstal l, G. Ippolito

Hellenic Center for I nfectious Dise ase Cont rol, A thens, G reece; National Institute fo r Infectio us Diseases L. Spallanzani, Ro me, Italy; Otto-Wag ner -Spital , Wien, Aust ria;

Rigshospitalet, Cope naghen, Denma rk; West Tallinn Ce ntral H ospital , Tallinn, Estonia; Hel sinki Unive rsity Cent ral Hos pital , Helsinki, Finlan d; Klinikum de r Johann Wolfgang

Goethe Unive rsitaet , Frankf urt, Ge r many; Swedish Instit ute for Infectious Dis ease Cont rol, S tockhol m, Sweden; Royal F ree Hospital, L ondon, United K ingdo m; Scarboroug h and

North East Yorkshi re NHS Trust, Sca rborough, United K ingdom

Background: Infectious

Diseas e (ID) medici ne is

formall y recogniz ed as an

independent speci alty in most

countri es i n Eur ope. T he

Eur opean Uni on of M edi cal

Speci alists has agreed i n 2002

a c ore c urricul um for training in

clinical ID, to facilitate the

devel opment of common

standards of trai ni ng within

Eur ope. Si mil arl y a c ore

curricul um was devel oped by

the Infectious Di seas es Soci ety

of America. H owever, neither

models mention trai ning in

prepar edness for highly

infecti ous dis ease (HID)

emergenci es, or the

management of patients who

have, or might have HID.

EUNID project

The European N etwor k for Infecti ous Disease (EUNID) is

an EC-funded network (EU

contract N° 2003207) of

Eur opean experts in the

management of patients with

HID.

One of EUNID’s agreed tasks is

to develop a core c urricul um for

training healthc are wor kers who

wil l work in high is olat ion units

(HIU), provi di ng car e for patients

with HIDs. T he a im i s to create a common framewor k in the EU

for produci ng HC Ws with

knowl edge and s kill s for treati ng

pat ients with HID , integrated

with existi ng infecti ous disease

training curricula in Eur ope. T he

obj ecti ve is to devel op a

consens us c ore curriculum, and

to design a theoretic al/practi cal course based on it.

Defini ti on of HID acc ording t o EUNID : a HID is transmissible fr om

person to person, causes life -thre atening illness, and presents a se rious hazard in he alth ca re setting and in the co mmunity, requiri ng specific

control measu res. The diseases/pa thogens listed are:

• V iral haemo rr hagic feve rs (ma rbur g, ebola, Crim ean Congo, and Lassa ),

and South American hae morrhagi c fever , (Juni n, Machupo, Sabia, and

Guanarito);

• SARS Co-V ;

• Emerging hig hly pathogenic strains of influenza vi rus

• Smallpox and other orthopox infections (eg mon keypox, came l pox, but excluding vaccinia vi rus )

• Other eme rging highly pathogenic agents, includ ing agents of deliber ate

release (eg pneu monic plag ue)

Methods: a questi onnaire was

sent to all EUNID partners

requiring their vi ews on the key

elements of optimum trai ni ng programme. Nine partners

(Austri a, D enmar k, Estonia,

Finl and, G er many, Greece,

Ital y, Sweden and the United

Ki ngdom) c ontributed to the

devel opment of c ore-curriculum.

The key elements most cited by

the partners ar e: i nfecti on

control iss ues, correct use of Personal Protecti ve

equipments, includi ng

procedures of donni ng and

removal, decontami nati on,

practic e in HIUs, waste

management issues, trans port

of pat ients affected by HIDs.

EUNID coor dination team then

devel oped a draft c ore

curricul um for health professi onals and a prototype

training course. The propos als

were then dis cussed by

partici pants at the s ec ond

annual EUNID meeting in April

2006 and the updated versions

were made avail abl e to partners

for further suggestions and

comments.

Resul ts: The EUNID core cur r icul um and pr ot otype co urse - The

curric ulum h as two main com ponents: theor etical knowledge and practical skills. Thu s, the course consists of tw o integ rated modules ,

and should be perfor med in the setting of health ca re facility with an

attached HIU. Module 1 (knowledg e), base d large ly on didactic teaching

(Table 1), p rovides the knowledge and eviden ce base fo r Module 2(practi cal skills ), which offe rs p ractical, skills -based trai ning (Table 2 ).

The aim of the m odules is to i ntroduc e the t rainees to the clinica l

aspects of HID and t heir i mpact on public health, and to the principles o f infection cont rol, th rough dida ctic teaching and p ractice -based

discussion. Recent a dvances will be highlighted, providin g an evidence-

based knowledge for mana ging patients who have a HID. A completeprototype co urse s chedule is available filling in EUNID web site

(www.eunid.c om)

-The design and constructio n char acteristi cs of a HIU, in cluding air changes, pressu re g radient and air filte ring, patient isolato r

-The different modalities of HIU in the EU

-The differen ce between an isolation room and HIU

-Crite ria for advising patient ad mission to a HIU

-Sources of a dvanced techn ical advice inc luding relevant nation al and inte rnational guidelines on uni t design, construction and m aintenance

HIU

-P rinciples of biohaza rd gro upings and risk assessment-Safe transpo rtation of biohaza rd sa mples within and between h ealth ca re facilities in accord ance with curr ent UNECE guidelines, inclu ding diffe rent types of

triple containe r

-How to choo se the app ropr iate containe r/s fo r the pa rticula r sa mple to be t ranspo rted -Safe patient t ransfer within and be tween healthcare facil ities

-The procedu res fo r handlin g a body post mo rtem

-Sources of a dvanced techn ical advice inc luding relevant nation al and inte rnational guidelines

Biosa fety iss ues

-Catego ries of disinfectant and thei r use in management of HID

-Safe and app ropriate decontamination of patients and eq uipme nt

-Waste manage ment issue s and manage ment of HID, in cluding resour ces for assistance


Disinf ecti on,

deco n tam ina tio n a nd

waste mana gemen t

-The different types of respi ratory and othe r PPE available for use in he alth ca re, including s pecialised respi ratory protect ive equip ment used for management of

HID, and an unde rstanding o f the pr inciples underlying th e selection of a ppropriate PPE


Personal pro tec tive

equi pmen t (PPE)

-The different types of infect ion cont rol pre cautions (standa rd, contact, respirato ry/droplet, ai rborne i nfection isolation) an d crite ria for thei r use

-Count ry-spe cific HIU isola tion technique s and the adva ntages and dis advantages of each-Disease -specific high- risk procedu res (e g aerosol-gen erating proced ures in SARS) and te chniques fo r ri sk reduction


Hospi tal i nfe cti on

con trol

-The principl es of the public health response to HID

-Systems fo r notifying/repo rting HI D in thei r own and oth er cou ntries

-Epidemiolog ic characterist ics that may distingui sh a naturally occu rri ng outb reak from a de liberate releas e event

-How and wh en to involve p ublic health au thoritie s in ma nagem entof HID

-The concept of syndro mic surveillance

-Public health responses to the delibe rate release of biol ogical agents

Public healt h a nd

HID

-Disease epi demiology and public health i mpact

-Mod e of tran smission-Clinical presentation, including ea rly recognition , differe ntial diagnosis , investigation, and m anage ment options

-Approp riate infection contr ol mea sures

-P re- and post exposure p reventive measu res-Approp riate manage ment of hospi tal and fa mily contact s

-Approp riate manage ment of an oc cupational exp osure


Disease-s peci fic

knowl edge

The specialist should be abl e to desc ribe/explainTo pic

Table 1: Pro posed EUNID c ore curr icul um for managemen t of HI D: the oretical kn owledge

-Safely use the country -specific HI U equip ment r elevant to thei r home country

-Dem onstrat e an awa reness of co untry-specific HIU equipment used e lsewhe re, including it s limita tionsand necessary i nfection cont rol p recautions

Coun try - sp ecific skills

-Dem onstrat e experience of the te am wo rk and c oordina tion needed to deal with HID patient

-Respond ap prop riately to a n occupational exposu re incident (eg blood splash, glove tear )

-Have pa rticipated in patient ad mission d rills/exe rcises

Team workin g

-Conduct bas ic airflow/pres sure c hecks

-Check a pla nned preventive maintenance schedule and its res ults, and discu ss these with t he facility engi neer

-Have pa rticipated in patient ad mission d rills/exe rcises

HIU

-Dem onstrat e the correct h and washing p rocedure

-Dem onstrat e the correct u se of alcohol g els for hand cleaning

-Dem onstrat e the correct u se and disposa l of needles an d shar p instru ments

-Dem onstrat e the correct u se of aseptic te chnique

-Dem onstrat e the correct s election, use, a nd safe dispos al of PPE appropriate to the risk

-Detect and respond approp riately to probl ems with the use of a n articl e of PPE

-Recognize when PPE is being used inapp ropriat ely

-Assist/cor rect a fellow HCW with the pro per process of donning/ remo ving PPE

Infec ti on c o ntrol

and use of PPE

-Distinguish t ypes of respir atory p rotectio n available fo r HCW against infectio us agents

-Dem onstrat e the correct s election, use, a nd safe decont aminat ion/disposal of each type

-Conduct a fit test and a fit c heck

-Detect p roble ms with the u se of each typ e of ma sk or respi rato r

-Show a fellow HC W how to use t he mas k or respi rator

Use o f respirat ory

prote ction

The specialist should be abl e toTo pic

Table 2: Pro posed EUNID c ore cur r icul um for managemen t of HI D: practical s kills

Discu ssion: al most all the pl ans for preparednes s and r espons e to the threats pos ed

by HIDs i dentif y the need for conti nued educ ati on and trai ni ng of HC Ws who would

have to manage these emergenci es. H owever, in the l ast decades Eur opean i nfecti ous

dis eas es speci alists have been rarel y involved i n the management of HID. Thus, there

is the need for increasi ng healthc are staff res ponse c apacity, to be abl e to rec ogni ze,

treat and coor dinate car e rel ated to HID and possi bl y rel ated public health

emergenci es. T he c urricul um and associated course outline we proposed have been

devel oped pri marily to augment current training i n HID management i n Europe. Thus, the target group for this trai ni ng acti vit y s hould pri marily be ID physic ians and

physici ans of other speci alti es that may be c all ed to manag e a pati ent with a HID (e.g.

Figure 1 – C ountries

participating to EU NID project

Transport of an highly

infectious p atient

Learning in small gro up

Web s ite:

www.euni d.com

Contacts:

euni d.s ecretary@i

nmi.it;

fusc o@i nmi.it

14

What is currently going on

• Definition of criteria for patient’s admission in

the HIUs;

• Definition of risk-benefits and safe management

of some medical procedures on patients with

HIDs. Intensive Care procedures, bronchoscopy,

gastroscopy, imaging exams (CT scan and RMI,

Chest X rays and Ultrasound), renal dialysis and

post-mortem examinations have been analyzed;

• Definition of a list of expert in Europe for the

management of patients with suspected or

confirmed HIDs.


From consensus to applicability:

from EUNID to EuroNHID

• European Network for Highly Infectious Diseases

(EuroNHID) is a new project accepted for co-funding

from European Commission;

• EuroNHID will start in next June, and will continue and

reinforce the work done during EUNID project

• Participating countries: Austria, Bulgaria, Denmark,

Finland, France, Germany, Greece, Ireland, Italy,

Luxembourg, Malta, Poland, Slovenia, Spain, UK.

15

From consensus to applicability:

from EUNID to EuroNHID

EuroNHID main objectives:

• Development of checklists for HIUs assessment in European Countries

• Checklist-based survey of HIUs capabilities and policy in European Countries

• Needs assessment as emerged from the survey and proposal for affordable improvements

european network for infectious diseases - eunid.eu workshop 22-23 may... · the diseases/pa...

Documents